Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -21.758% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a Cc1ccc(OCC(=O)NC2CC(C)(C)NC(C)(C)C2)cc1C
b Cc1cccc(N=Nc2c(C)[nH]n(C(N)=S)c2=O)c1C
c Cc1cc(Cl)ccc1NC(=O)COC(=O)c1nc2nccc(C)n2n1
d Cc1ccccc1OCC(=O)NNC(=O)CSc1nc(N)cc(N)n1
e Cc1cccc(NC(=O)CSCC(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)c1
Answer: e. Cc1cccc(NC(=O)CSCC(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(NC(=O)CSCC(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)c1
Cc1cccc(NC(=O)CSCC(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)c1
N-(3-methylphenyl)-2-[2-oxo-2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]sulfanylacetamide